checkAd

     305  0 Kommentare ONWARD Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication

    Nature Medicine published Up-LIFT pivotal trial results

    Company will discuss pivotal trial results during webcast this week with company leaders and study principal investigators and participants

    EINDHOVEN, the Netherlands, May 21, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that on Thursday, May 23rd at 2:30pm CET/8:30am ET following a brief Q1 Business Update, CEO Dave Marver will host a discussion of Up-LIFT pivotal trial results with a panel of company leaders, study principal investigators, and study participants. The Up-LIFT trial demonstrated the safety and effectiveness of external ARC-EX Therapy to improve hand and arm function after spinal cord injury.

    Panelists will include Up-LIFT principal investigators Drs. Jim Guest, Chet Moritz, and Candace Tefertiller, trial participants Sherown Campbell and Jessie Owen, and ONWARD Medical VP Clinical, Regulatory, and Quality Erika Ross Ellison.

    To join the webcast via Zoom, please register using this link.

    Participants may also join by phone:

    +32 2 290 9360 (Belgium)

    Lesen Sie auch

    +33 1 7037 2246 (France)

    +49 69 3807 9884 (Germany)

    +31 20 794 0854 (Netherlands)

    +41 22 591 0156 (Switzerland)

    +44 203 481 5240 (United Kingdom)

    +1 346 248 7799 (US)

    Additional telephone numbers available

    Meeting ID: 879 5741 2479

    A recording of the webcast will be available on the Company’s website following the live event.

    To learn more about ONWARD Medical’s commitment to partnering with the SCI Community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visit ONWD.com.

    *All ONWARD Medical devices and therapies, including but not limited to ARC-IM, ARC-EX, ARC-BCI, and ARC Therapy, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

    About ONWARD Medical   

    ONWARD Medical is a medical technology company creating therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disabilities. Building on more than a decade of scientific discovery, preclinical, and clinical research conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company has developed ARC Therapy, which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA).

    Seite 1 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    ONWARD Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication Nature Medicine published Up-LIFT pivotal trial results Company will discuss pivotal trial results during webcast this week with company leaders and study principal investigators and participants EINDHOVEN, the Netherlands, May 21, 2024 (GLOBE …

    Schreibe Deinen Kommentar

    Disclaimer